What does Dr. Ingeborg Hofman, Huisarts do?

Dr. Ingeborg Hofman, Huisarts is a general practice in Haaltert. Private Limited, started on 2 April 2012, 2 establishments.

What is the address of Dr. Ingeborg Hofman, Huisarts?

The registered office of Dr. Ingeborg Hofman, Huisarts is located at Molenveld(HA) 39, 9450 Haaltert.

Is Dr. Ingeborg Hofman, Huisarts still active?

Yes. According to the CBE (17 September 2026) Dr. Ingeborg Hofman, Huisarts is active, legal situation “Normale toestand”, started on 2 April 2012.

Is Dr. Ingeborg Hofman, Huisarts registered on Peppol?

Yes, Dr. Ingeborg Hofman, Huisarts is registered on the Peppol network with ID 0208:0844908602.

What is the enterprise number of Dr. Ingeborg Hofman, Huisarts?

The enterprise number of Dr. Ingeborg Hofman, Huisarts is BE0844908602.

When was Dr. Ingeborg Hofman, Huisarts founded?

Dr. Ingeborg Hofman, Huisarts was founded on 2 April 2012.

Who are the directors of Dr. Ingeborg Hofman, Huisarts?

According to the 2025 annual accounts, the directors of Dr. Ingeborg Hofman, Huisarts are: Wim Janssens, Ingeborg Hofman.

Is Dr. Ingeborg Hofman, Huisarts a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 April 2012; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did Dr. Ingeborg Hofman, Huisarts make in 2025?

Dr. Ingeborg Hofman, Huisarts posted a profit after taxes of € 82,445 in financial year 2025.

What is the revenue of Dr. Ingeborg Hofman, Huisarts?

As a small company, Dr. Ingeborg Hofman, Huisarts is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 172,208.

Dr. Ingeborg Hofman, Huisarts (Private Limited)

Dossier Dr. Ingeborg Hofman, Huisarts, printed on 17 September 2026 from databakkes.be/en/0844908602/dr-ingeborg-hofman-huisarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Ingeborg Hofman, Huisarts from Haaltert, company number BE0844908602, closed financial year 2025 with a result of € 82,445 after tax. For that financial year Dr. Ingeborg Hofman, Huisarts recorded a gross margin of € 172,208 and equity of € 288,076. Compared with financial year 2024, the result moved from € 53,378 to € 82,445. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 19, 2026.

What it is worth Growing

€ 288,076

▲ 28% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 82,445

▲ 54% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 171,910

▲ 73% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 19,049 paid out

23 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 36,530

▲ 35% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 74,413

▲ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 25,699

▼ 27% vs 2024

€ 9,992 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 33,621

▲ € 33,214 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 10,590

▲ 61% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 41,805 Gross margin 2022: € 41,805 First fiscal year in the series	€ 69,976 Gross margin 2023: € 69,976 ▲ 67% vs 2022 (€ 41,805) Favourable step	€ 114,981 Gross margin 2024: € 114,981 ▲ 64% vs 2023 (€ 69,976) Favourable step	€ 172,208 Gross margin 2025: € 172,208 ▲ 50% vs 2024 (€ 114,981) Favourable step	▲ 50%
Profit after taxes	€ 22,801 Profit after taxes 2022: € 22,801 First fiscal year in the series	€ 40,415 Profit after taxes 2023: € 40,415 ▲ 77% vs 2022 (€ 22,801) Favourable step	€ 53,378 Profit after taxes 2024: € 53,378 ▲ 32% vs 2023 (€ 40,415) Favourable step	€ 82,445 Profit after taxes 2025: € 82,445 ▲ 54% vs 2024 (€ 53,378) Favourable step	▲ 54%
Equity	€ 174,954 Equity 2022: € 174,954 First fiscal year in the series	€ 197,671 Equity 2023: € 197,671 ▲ 13% vs 2022 (€ 174,954) Favourable step	€ 224,680 Equity 2024: € 224,680 ▲ 14% vs 2023 (€ 197,671) Favourable step	€ 288,076 Equity 2025: € 288,076 ▲ 28% vs 2024 (€ 224,680) Favourable step	▲ 28%
Total debts	€ 13,638 Total debts 2022: € 13,638 First fiscal year in the series	€ 12,260 Total debts 2023: € 12,260 ▼ 10% vs 2022 (€ 13,638) Favourable step	€ 43,495 Total debts 2024: € 43,495 ▲ 255% vs 2023 (€ 12,260) Unfavourable step	€ 71,689 Total debts 2025: € 71,689 ▲ 65% vs 2024 (€ 43,495) Unfavourable step	▲ 65%
Cash	€ 77,274 Cash 2022: € 77,274 First fiscal year in the series	€ 91,624 Cash 2023: € 91,624 ▲ 19% vs 2022 (€ 77,274) Favourable step	€ 99,649 Cash 2024: € 99,649 ▲ 9% vs 2023 (€ 91,624) Favourable step	€ 171,910 Cash 2025: € 171,910 ▲ 73% vs 2024 (€ 99,649) Favourable step	▲ 73%
Retained profit	€ 162,554 Retained profit 2022: € 162,554 First fiscal year in the series	€ 185,271 Retained profit 2023: € 185,271 ▲ 14% vs 2022 (€ 162,554) Favourable step	€ 212,280 Retained profit 2024: € 212,280 ▲ 15% vs 2023 (€ 185,271) Favourable step	€ 275,676 Retained profit 2025: € 275,676 ▲ 30% vs 2024 (€ 212,280) Favourable step	▲ 30%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 17,698 Dividend 2023: € 17,698 Unchanged (€ 0) Unchanged	€ 26,370 Dividend 2024: € 26,370 ▲ 49% vs 2023 (€ 17,698) Unchanged	€ 19,049 Dividend 2025: € 19,049 ▼ 28% vs 2024 (€ 26,370) Unchanged	▼ 28%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 35,323 Bank debt 2024: € 35,323 Unchanged (€ 0) Unfavourable step	€ 25,699 Bank debt 2025: € 25,699 ▼ 27% vs 2024 (€ 35,323) Favourable step	▼ 27%
Balance sheet total	€ 188,592 Balance sheet total 2022: € 188,592 First fiscal year in the series	€ 209,931 Balance sheet total 2023: € 209,931 ▲ 11% vs 2022 (€ 188,592) Unchanged	€ 268,175 Balance sheet total 2024: € 268,175 ▲ 28% vs 2023 (€ 209,931) Unchanged	€ 359,765 Balance sheet total 2025: € 359,765 ▲ 34% vs 2024 (€ 268,175) Unchanged	▲ 34%

Key figures of Dr. Ingeborg Hofman, Huisarts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Ingeborg Hofman, Huisarts?

What happened at Dr. Ingeborg Hofman, Huisarts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 19, 2026 New annual accounts for financial year 2025: profit of € 82,445 (▲ 54% vs 2024). Source: NBB ↗
2024 Wim Janssens became a director. NBB
2023 Ingeborg Hofman became a director. NBB
Sep 1, 2022 New establishment in Haaltert. KBO
Apr 2, 2012 Start of the company according to the CBE. KBO
Mar 29, 2012 New establishment in Haaltert. KBO

In short

From € 22,801 profit in 2022 to € 82,445 profit in 2025.

Paid € 80,352 in corporate taxes since 2022.

Best year ever: 2025, with € 82,445 profit.

Paid out € 63,117 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Ingeborg Hofman, Huisarts? We notify you, reason included.

Follow Dr. Ingeborg Hofman, Huisarts

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Wim Janssens

Ingeborg Hofman

Dr. Ingeborg Hofman, Huisarts

Windimmo BV 50%

Behind Dr. Ingeborg Hofman, Huisarts are Wim Janssens and Ingeborg Hofman. It owns 50% of Windimmo BV itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Wim Janssens

Director

since 2024

Ingeborg Hofman

Director

Also active at: Windimmo

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Molenveld(HA) 39

9450 Haaltert

2.344.244.629

Windmolenstraat(HA) 150

9450 Haaltert

Active since 1 September 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0844.908.602
VAT number: BE 0844.908.602
Registered office: Molenveld(HA) 39, 9450 Haaltert
Names & denominations: Dr. Ingeborg Hofman, Huisarts
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 April 2012
Peppol: Active · Active since 27 Mar 2026
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗